---
title: Fortrea vs Genelife Clinical Research Pvt. Ltd.
slug_a: fortrea
slug_b: genelifecr
site: cro
review_signal_gate: closed
canonical_path: /compare/fortrea/genelifecr
---

# Fortrea vs Genelife Clinical Research Pvt. Ltd.

Side-by-side profile data from each company listing on this directory.

## Fortrea

- Profile: [/companies/fortrea](/companies/fortrea)

Fortrea — Fortrea is a leading CRO advancing clinical trials through patient-focused clinical solutions that accelerate clinical development and drive trial success.

Services: 17. Modalities: 6. Indications: 13. Locations: 54. Certifications: 2. The strongest documented coverage currently appears in locations (54).

### Services

- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Central Laboratory Services
- Clinical Imaging Core Lab
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- Japan PMDA Regulatory Strategy
- China NMPA Regulatory Strategy

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Cell Therapy
- Gene Therapy
- Vaccine

### Indications

- Oncology
- Immunology
- Neurology
- Metabolic
- Cardiovascular
- Infectious Disease
- Rare Disease
- Respiratory
- Dermatology
- Ophthalmology
- Gastroenterology
- Nephrology
- Women's Health

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV
- Real-World Evidence (RWE) / Registries

### Sourcing models

- Functional Service Provider (FSP)
- Full-Service Outsourcing (FSO)

## Genelife Clinical Research Pvt. Ltd.

- Profile: [/companies/genelifecr](/companies/genelifecr)

Genelife Clinical Research Pvt. Ltd. — CDSCO-registered CRO in India running Phase I–IV trials, real world evidence studies, and bioequivalence (BABE) studies for pharma, biotech, and device sponsors. Offices in Mumbai, California, Cambridge, and Hamburg support multi-regional programs.

Services: 13. Modalities: 4. Indications: 4. Locations: 4. Certifications: 1. The strongest documented coverage currently appears in services (13).

### Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Central Laboratory Services
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy

### Modalities

- Small Molecule
- Biologics (Other)
- Peptide
- Vaccine

### Indications

- Oncology
- Neurology
- Cardiovascular
- Dermatology

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV
- Real-World Evidence (RWE) / Registries

### Sourcing models

- Full-Service Outsourcing (FSO)